Unsafe Handling of Hazardous Medications During G-tube Administration
Summary
The facility failed to follow safe hazardous drug handling procedures before preparing and administering hazardous medications for a resident with diagnoses that included benign prostatic hyperplasia and attention to gastrostomy. The resident’s record showed he was admitted to the facility on 6/17/2024 and later readmitted, and his MDS indicated he was dependent on staff for multiple activities of daily living and that eating was not attempted due to medical condition or safety concerns. During a concurrent observation and interview, an LVN prepared seven medications for administration via G-tube. The LVN removed bicalutamide 50 mg from its bubble pack without gloves, placed it in a small transparent plastic bag, and crushed it without wearing gloves. The LVN also removed finasteride 5 mg from its bubble pack, placed it in a small transparent plastic bag, and crushed it while wearing gloves. The LVN stated she wore gloves for finasteride because she could touch it accidentally, but did not wear gloves when removing bicalutamide because she was not going to touch the tablet. The medication labels showed bicalutamide with directions to take one tablet by mouth daily with an additional note that the chart had changed, and finasteride with directions to take one tablet by mouth daily and to use gloves when handling. The LVN stated the cards indicated by mouth but the order had been changed in the eMAR to indicate by G-tube. She then removed her gloves and continued crushing the remaining medications. Later, the LVN stated she had researched Casodex and finasteride and recognized both as hazardous medications, and the DON stated the facility did not have the necessary chemotherapy gloves or gowns to aid in safe preparation and administration of hazardous drugs. The facility policy titled USP Chapter <800>: Hazardous Drug identified Casodex and finasteride on its hazardous medication list and stated to always wear chemo-rated gloves when handling hazardous medications and not to crush, split, or open hazardous tablets or capsules unless pharmacy-approved containment is used.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.